Demonstrates that reovirus σ1 mutants improve infection in breast cancer cells by enhancing sialic acid attachment, suggesting novel approaches for oncolytic therapies.
Reoviruses are promising oncolytic agents, yet clinical efficacy can be hindered by heterogeneous receptor expression in tumors. This study demonstrates that reovirus can bypass high-affinity receptor requirements by optimizing sialic acid interactions or incorporating RGD motifs. Crucially, the data reveal that wild-type reovirus attachment to sialic acids is thermally unstable at physiological temperature (37°C), a restriction masked by traditional 4°C assays. Specific mutations were found to stabilize these interactions at 37°C, providing a mechanistic basis for viral adaptation to receptor-deficient environments. These findings establish new experimental approaches to study attachment at 37°C, which can be applied broadly to discover unanticipated mutational effects on viral entry. Ultimately, evaluating virus-cell attachment under physiological conditions is essential for accurately predicting viral tropism and facilitates the design of next-generation oncolytic therapies better equipped to overcome receptor scarcity and thermal barriers in complex tumor environments.
No takes yet. Share an insight, caveat, or question.
Taal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: